Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank92
3Y CAGR+13.7%
5Y CAGR+25.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+13.7%/yr
vs +34.6%/yr prior
5Y CAGR
+25.4%/yr
Recent deceleration
Acceleration
-20.9pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $86.50M | -15.2% |
| 2024 | $101.96M | +39.1% |
| 2023 | $73.32M | +24.7% |
| 2022 | $58.77M | +40.7% |
| 2021 | $41.77M | +49.6% |
| 2020 | $27.92M | +59.3% |
| 2019 | $17.53M | -2.0% |
| 2018 | $17.89M | +42.6% |
| 2017 | $12.54M | +26.8% |
| 2016 | $9.89M | - |